These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19433773)

  • 1. Does it matter when drugs are taken?
    Morgan TO
    Hypertension; 2009 Jul; 54(1):23-4. PubMed ID: 19433773
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE
    Hypertension; 2009 Jul; 54(1):40-6. PubMed ID: 19433778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
    White WB; Cleveland JM; Rolleri RL;
    J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated linoleic acid supplementation enhances antihypertensive effect of ramipril in Chinese patients with obesity-related hypertension.
    Zhao WS; Zhai JJ; Wang YH; Xie PS; Yin XJ; Li LX; Cheng KL
    Am J Hypertens; 2009 Jun; 22(6):680-6. PubMed ID: 19300423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label, noncomparative, multicenter study of ramipril in the treatment of patients with mild-to-moderate hypertension.
    Sadick A; Yusuf MZ; Reuter M
    Clin Ther; 1996; 18(6):1161-8. PubMed ID: 9001832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians.
    Moran A; Simon JA; Shiboski S; Pickering TG; Waters D; Rotter JI; Lyon C; Nickerson D; Yang H; Saad M; Hsueh W; Krauss RM
    Am J Hypertens; 2007 Aug; 20(8):884-91. PubMed ID: 17679038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ramipril effects on 24 hour profile of blood pressure in patients with mild and moderate hypertension].
    Kukushkin SK; Lebedev AV; Manoshkina EM; Shamarin VM
    Ter Arkh; 1998; 70(9):69-71. PubMed ID: 9821232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New possibilities for preparations suppressing the activity of the angiotensin-converting enzyme].
    Bender N
    Ter Arkh; 1992; 64(9):101-3. PubMed ID: 1481144
    [No Abstract]   [Full Text] [Related]  

  • 9. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ramipril, a new antagonist of angiotensin converting enzyme].
    Korolkovas A; Brandão DC; Rosito F
    Arq Bras Cardiol; 1993 Feb; 60(2):115-22. PubMed ID: 8240047
    [No Abstract]   [Full Text] [Related]  

  • 12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Wright M; Lukashevich V; Keefe DL
    Cardiovasc Ther; 2010 Dec; 28(6):344-9. PubMed ID: 20406241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of hypertension with expanded outlook. Constant pressure decline and organ protection].
    MMW Fortschr Med; 2007 Dec; 149(49-50):52-3. PubMed ID: 18236984
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Gualtierotti R; Lazzari P; Derosa G; D'Angelo A
    Expert Opin Pharmacother; 2013 Dec; 14(18):2463-73. PubMed ID: 24195786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative assessment of antihypertensive effects of angiotensin-converting enzyme inhibitors ramipril and captopril in patients with hypertension in ambulatory settings].
    Lebedev AV; Kukushkin SK; Manoshkina EM; Shamarin VM; Deev AD
    Kardiologiia; 2003; 43(3):71-2. PubMed ID: 12913982
    [No Abstract]   [Full Text] [Related]  

  • 19. The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy.
    Martino TA; Tata N; Simpson JA; Vanderlaan R; Dawood F; Kabir MG; Khaper N; Cifelli C; Podobed P; Liu PP; Husain M; Heximer S; Backx PH; Sole MJ
    J Am Coll Cardiol; 2011 May; 57(20):2020-8. PubMed ID: 21565639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.